Correlation Between Bioteque and Apex Biotechnology
Can any of the company-specific risk be diversified away by investing in both Bioteque and Apex Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioteque and Apex Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioteque and Apex Biotechnology Corp, you can compare the effects of market volatilities on Bioteque and Apex Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioteque with a short position of Apex Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioteque and Apex Biotechnology.
Diversification Opportunities for Bioteque and Apex Biotechnology
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Bioteque and Apex is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Bioteque and Apex Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apex Biotechnology Corp and Bioteque is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioteque are associated (or correlated) with Apex Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apex Biotechnology Corp has no effect on the direction of Bioteque i.e., Bioteque and Apex Biotechnology go up and down completely randomly.
Pair Corralation between Bioteque and Apex Biotechnology
Assuming the 90 days trading horizon Bioteque is expected to generate 0.68 times more return on investment than Apex Biotechnology. However, Bioteque is 1.47 times less risky than Apex Biotechnology. It trades about 0.05 of its potential returns per unit of risk. Apex Biotechnology Corp is currently generating about 0.02 per unit of risk. If you would invest 10,564 in Bioteque on September 4, 2024 and sell it today you would earn a total of 2,036 from holding Bioteque or generate 19.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Bioteque vs. Apex Biotechnology Corp
Performance |
Timeline |
Bioteque |
Apex Biotechnology Corp |
Bioteque and Apex Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bioteque and Apex Biotechnology
The main advantage of trading using opposite Bioteque and Apex Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioteque position performs unexpectedly, Apex Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apex Biotechnology will offset losses from the drop in Apex Biotechnology's long position.Bioteque vs. StShine Optical Co | Bioteque vs. United Orthopedic | Bioteque vs. Excelsior Medical Co | Bioteque vs. Pacific Hospital Supply |
Apex Biotechnology vs. Grape King Bio | Apex Biotechnology vs. Standard Chemical Pharmaceutical | Apex Biotechnology vs. China Steel Chemical | Apex Biotechnology vs. Sinphar Pharmaceutical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |